Collegium Pharmaceutical Shares Owned By Insiders vs. Price To Sales
| COLL Stock | USD 30.50 0.21 0.68% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.65 | 0.5755 |
|
|
For Collegium Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Collegium Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Collegium Pharmaceutical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Collegium Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Collegium Pharmaceutical over time as well as its relative position and ranking within its peers.
Collegium |
Collegium Pharmaceutical's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.49) | Earnings Share 2.34 | Revenue Per Share 18.538 | Quarterly Revenue Growth 0.165 | Return On Assets 0.0968 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Collegium Pharmaceutical Price To Sales vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Collegium Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Collegium Pharmaceutical value to that of its competitors to determine the firm's financial worth. Collegium Pharmaceutical is rated below average in shares owned by insiders category among its peers. It also is rated below average in price to sales category among its peers fabricating about 1.01 of Price To Sales per Shares Owned By Insiders. At this time, Collegium Pharmaceutical's Price To Sales Ratio is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Collegium Pharmaceutical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Collegium Price To Sales vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Collegium Pharmaceutical |
| = | 1.64 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Collegium Pharmaceutical |
| = | 1.65 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Collegium Price To Sales Comparison
Collegium Pharmaceutical is currently under evaluation in price to sales category among its peers.
Collegium Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Collegium Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Collegium Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Collegium Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Collegium Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 14 K | 14.7 K | |
| Operating Income | 167 M | 175.3 M | |
| Income Before Tax | 75.7 M | 79.5 M | |
| Total Other Income Expense Net | -91.2 M | -86.7 M | |
| Net Income | 48.2 M | 50.6 M | |
| Income Tax Expense | 27.6 M | 29 M | |
| Net Income From Continuing Ops | 48.2 M | 50.6 M | |
| Net Loss | -28.8 M | -30.2 M | |
| Non Operating Income Net Other | 1.2 M | 694.8 K | |
| Net Interest Income | -67.7 M | -64.3 M | |
| Interest Income | 15.6 M | 16.4 M | |
| Change To Netincome | 13 M | 13.7 M | |
| Net Income Per Share | 1.43 | 1.50 | |
| Income Quality | 5.71 | 5.99 | |
| Net Income Per E B T | 0.64 | 0.67 |
Collegium Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Collegium Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Collegium Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Collegium Pharmaceutical's important profitability drivers and their relationship over time.
Use Collegium Pharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collegium Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Collegium Pharmaceutical Pair Trading
Collegium Pharmaceutical Pair Trading Analysis
The ability to find closely correlated positions to Collegium Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collegium Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collegium Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collegium Pharmaceutical to buy it.
The correlation of Collegium Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collegium Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collegium Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collegium Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Collegium Pharmaceutical position
In addition to having Collegium Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Outsourcing Thematic Idea Now
Outsourcing
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
To fully project Collegium Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Collegium Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Collegium Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.